 | • レポートコード：MRC2-11QY02082 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、183ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医薬品有効成分のグローバル市場について調査・分析したレポートです。種類別（革新的医薬品有効成分、ジェネリック医薬品有効成分）市場規模、用途別（腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医薬品有効成分の競争状況、市場シェア ・世界の医薬品有効成分市場：種類別市場規模 2015年-2020年（革新的医薬品有効成分、ジェネリック医薬品有効成分） ・世界の医薬品有効成分市場：種類別市場規模予測 2021年-2026年（革新的医薬品有効成分、ジェネリック医薬品有効成分） ・世界の医薬品有効成分市場：用途別市場規模 2015年-2020年（腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他） ・世界の医薬品有効成分市場：用途別市場規模予測 2021年-2026年（腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他） ・北米の医薬品有効成分市場分析：米国、カナダ ・ヨーロッパの医薬品有効成分市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医薬品有効成分市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医薬品有効成分市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医薬品有効成分市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva、Novartis、Pfizer、Johnson & Johnson、Mylan、North China Pharmaceutical Group、Dr. Reddy’s Laboratories、Roche、Aurobindo pharma、Sun Pharmaceutical Industries、Boehringer Ingelheim GmbH、Bayer、BASF、DSM、Zhejiang Medicine、Biocon、Johnson Matthey、Hisun Pharmacy、Cambrex、Shandong Xinhua Pharmaceutical、Lonza group、Huahai Pharmaceutical、Haerbin Pharmaceutical Group、Cipla、Tian Yao、Lupin、North East Pharmaceutical、Albemarle、Shandong Lukang Pharmaceutical、Jiangsu Hengrui Medicine ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Active Pharma Ingredient Market
The global Active Pharma Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Active Pharma Ingredient Scope and Market Size
Active Pharma Ingredient market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharma Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Active Pharma Ingredient market is segmented into
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Segment by Application, the Active Pharma Ingredient market is segmented into
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications
Regional and Country-level Analysis
The Active Pharma Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Active Pharma Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Active Pharma Ingredient Market Share Analysis
Active Pharma Ingredient market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Active Pharma Ingredient business, the date to enter into the Active Pharma Ingredient market, Active Pharma Ingredient product introduction, recent developments, etc.
The major vendors covered:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
1 Study Coverage
1.1 Active Pharma Ingredient Product Introduction
1.2 Market Segments
1.3 Key Active Pharma Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Active Pharma Ingredient Market Size Growth Rate by Type
1.4.2 Innovative Active Pharmaceutical Ingredients
1.4.3 Generic Active Pharmaceutical Ingredients
1.5 Market by Application
1.5.1 Global Active Pharma Ingredient Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiovascular Disease
1.5.4 Diabetes
1.5.5 Central Nervous System and Neurological Disorders
1.5.6 Endocrinology
1.5.7 Other Therapeutic Applications
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Active Pharma Ingredient Market Size, Estimates and Forecasts
2.1.1 Global Active Pharma Ingredient Revenue 2015-2026
2.1.2 Global Active Pharma Ingredient Sales 2015-2026
2.2 Global Active Pharma Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Active Pharma Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Active Pharma Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Active Pharma Ingredient Competitor Landscape by Players
3.1 Active Pharma Ingredient Sales by Manufacturers
3.1.1 Active Pharma Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Active Pharma Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Active Pharma Ingredient Revenue by Manufacturers
3.2.1 Active Pharma Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Active Pharma Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Active Pharma Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Active Pharma Ingredient Revenue in 2019
3.2.5 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Active Pharma Ingredient Price by Manufacturers
3.4 Active Pharma Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Active Pharma Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharma Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharma Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Active Pharma Ingredient Market Size by Type (2015-2020)
4.1.1 Global Active Pharma Ingredient Sales by Type (2015-2020)
4.1.2 Global Active Pharma Ingredient Revenue by Type (2015-2020)
4.1.3 Active Pharma Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Active Pharma Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Active Pharma Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Active Pharma Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Active Pharma Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Active Pharma Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Active Pharma Ingredient Market Size by Application (2015-2020)
5.1.1 Global Active Pharma Ingredient Sales by Application (2015-2020)
5.1.2 Global Active Pharma Ingredient Revenue by Application (2015-2020)
5.1.3 Active Pharma Ingredient Price by Application (2015-2020)
5.2 Active Pharma Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Active Pharma Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Active Pharma Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Pharma Ingredient Price Forecast by Application (2021-2026)
6 North America
6.1 North America Active Pharma Ingredient by Country
6.1.1 North America Active Pharma Ingredient Sales by Country
6.1.2 North America Active Pharma Ingredient Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Active Pharma Ingredient Market Facts & Figures by Type
6.3 North America Active Pharma Ingredient Market Facts & Figures by Application
7 Europe
7.1 Europe Active Pharma Ingredient by Country
7.1.1 Europe Active Pharma Ingredient Sales by Country
7.1.2 Europe Active Pharma Ingredient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharma Ingredient Market Facts & Figures by Type
7.3 Europe Active Pharma Ingredient Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Active Pharma Ingredient by Region
8.1.1 Asia Pacific Active Pharma Ingredient Sales by Region
8.1.2 Asia Pacific Active Pharma Ingredient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Type
8.3 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Application
9 Latin America
9.1 Latin America Active Pharma Ingredient by Country
9.1.1 Latin America Active Pharma Ingredient Sales by Country
9.1.2 Latin America Active Pharma Ingredient Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Active Pharma Ingredient Market Facts & Figures by Type
9.3 Central & South America Active Pharma Ingredient Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Active Pharma Ingredient by Country
10.1.1 Middle East and Africa Active Pharma Ingredient Sales by Country
10.1.2 Middle East and Africa Active Pharma Ingredient Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Type
10.3 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Application
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharma Ingredient Products Offered
11.1.5 Teva Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Active Pharma Ingredient Products Offered
11.2.5 Novartis Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Active Pharma Ingredient Products Offered
11.3.5 Pfizer Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Active Pharma Ingredient Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Active Pharma Ingredient Products Offered
11.5.5 Mylan Related Developments
11.6 North China Pharmaceutical Group
11.6.1 North China Pharmaceutical Group Corporation Information
11.6.2 North China Pharmaceutical Group Description and Business Overview
11.6.3 North China Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 North China Pharmaceutical Group Active Pharma Ingredient Products Offered
11.6.5 North China Pharmaceutical Group Related Developments
11.7 Dr. Reddy’s Laboratories
11.7.1 Dr. Reddy’s Laboratories Corporation Information
11.7.2 Dr. Reddy’s Laboratories Description and Business Overview
11.7.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Products Offered
11.7.5 Dr. Reddy’s Laboratories Related Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Description and Business Overview
11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche Active Pharma Ingredient Products Offered
11.8.5 Roche Related Developments
11.9 Aurobindo pharma
11.9.1 Aurobindo pharma Corporation Information
11.9.2 Aurobindo pharma Description and Business Overview
11.9.3 Aurobindo pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aurobindo pharma Active Pharma Ingredient Products Offered
11.9.5 Aurobindo pharma Related Developments
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Corporation Information
11.10.2 Sun Pharmaceutical Industries Description and Business Overview
11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Products Offered
11.10.5 Sun Pharmaceutical Industries Related Developments
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharma Ingredient Products Offered
11.1.5 Teva Related Developments
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Description and Business Overview
11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer Products Offered
11.12.5 Bayer Related Developments
11.13 BASF
11.13.1 BASF Corporation Information
11.13.2 BASF Description and Business Overview
11.13.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.13.4 BASF Products Offered
11.13.5 BASF Related Developments
11.14 DSM
11.14.1 DSM Corporation Information
11.14.2 DSM Description and Business Overview
11.14.3 DSM Sales, Revenue and Gross Margin (2015-2020)
11.14.4 DSM Products Offered
11.14.5 DSM Related Developments
11.15 Zhejiang Medicine
11.15.1 Zhejiang Medicine Corporation Information
11.15.2 Zhejiang Medicine Description and Business Overview
11.15.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Zhejiang Medicine Products Offered
11.15.5 Zhejiang Medicine Related Developments
11.16 Biocon
11.16.1 Biocon Corporation Information
11.16.2 Biocon Description and Business Overview
11.16.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Biocon Products Offered
11.16.5 Biocon Related Developments
11.17 Johnson Matthey
11.17.1 Johnson Matthey Corporation Information
11.17.2 Johnson Matthey Description and Business Overview
11.17.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Johnson Matthey Products Offered
11.17.5 Johnson Matthey Related Developments
11.18 Hisun Pharmacy
11.18.1 Hisun Pharmacy Corporation Information
11.18.2 Hisun Pharmacy Description and Business Overview
11.18.3 Hisun Pharmacy Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Hisun Pharmacy Products Offered
11.18.5 Hisun Pharmacy Related Developments
11.19 Cambrex
11.19.1 Cambrex Corporation Information
11.19.2 Cambrex Description and Business Overview
11.19.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Cambrex Products Offered
11.19.5 Cambrex Related Developments
11.20 Shandong Xinhua Pharmaceutical
11.20.1 Shandong Xinhua Pharmaceutical Corporation Information
11.20.2 Shandong Xinhua Pharmaceutical Description and Business Overview
11.20.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Shandong Xinhua Pharmaceutical Products Offered
11.20.5 Shandong Xinhua Pharmaceutical Related Developments
11.21 Lonza group
11.21.1 Lonza group Corporation Information
11.21.2 Lonza group Description and Business Overview
11.21.3 Lonza group Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Lonza group Products Offered
11.21.5 Lonza group Related Developments
11.22 Huahai Pharmaceutical
11.22.1 Huahai Pharmaceutical Corporation Information
11.22.2 Huahai Pharmaceutical Description and Business Overview
11.22.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Huahai Pharmaceutical Products Offered
11.22.5 Huahai Pharmaceutical Related Developments
11.23 Haerbin Pharmaceutical Group
11.23.1 Haerbin Pharmaceutical Group Corporation Information
11.23.2 Haerbin Pharmaceutical Group Description and Business Overview
11.23.3 Haerbin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Haerbin Pharmaceutical Group Products Offered
11.23.5 Haerbin Pharmaceutical Group Related Developments
11.24 Cipla
11.24.1 Cipla Corporation Information
11.24.2 Cipla Description and Business Overview
11.24.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Cipla Products Offered
11.24.5 Cipla Related Developments
11.25 Tian Yao
11.25.1 Tian Yao Corporation Information
11.25.2 Tian Yao Description and Business Overview
11.25.3 Tian Yao Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Tian Yao Products Offered
11.25.5 Tian Yao Related Developments
11.26 Lupin
11.26.1 Lupin Corporation Information
11.26.2 Lupin Description and Business Overview
11.26.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.26.4 Lupin Products Offered
11.26.5 Lupin Related Developments
11.27 North East Pharmaceutical
11.27.1 North East Pharmaceutical Corporation Information
11.27.2 North East Pharmaceutical Description and Business Overview
11.27.3 North East Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.27.4 North East Pharmaceutical Products Offered
11.27.5 North East Pharmaceutical Related Developments
11.28 Albemarle
11.28.1 Albemarle Corporation Information
11.28.2 Albemarle Description and Business Overview
11.28.3 Albemarle Sales, Revenue and Gross Margin (2015-2020)
11.28.4 Albemarle Products Offered
11.28.5 Albemarle Related Developments
11.29 Shandong Lukang Pharmaceutical
11.29.1 Shandong Lukang Pharmaceutical Corporation Information
11.29.2 Shandong Lukang Pharmaceutical Description and Business Overview
11.29.3 Shandong Lukang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.29.4 Shandong Lukang Pharmaceutical Products Offered
11.29.5 Shandong Lukang Pharmaceutical Related Developments
11.30 Jiangsu Hengrui Medicine
11.30.1 Jiangsu Hengrui Medicine Corporation Information
11.30.2 Jiangsu Hengrui Medicine Description and Business Overview
11.30.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
11.30.4 Jiangsu Hengrui Medicine Products Offered
11.30.5 Jiangsu Hengrui Medicine Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Active Pharma Ingredient Market Estimates and Projections by Region
12.1.1 Global Active Pharma Ingredient Sales Forecast by Regions 2021-2026
12.1.2 Global Active Pharma Ingredient Revenue Forecast by Regions 2021-2026
12.2 North America Active Pharma Ingredient Market Size Forecast (2021-2026)
12.2.1 North America: Active Pharma Ingredient Sales Forecast (2021-2026)
12.2.2 North America: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.2.3 North America: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
12.3 Europe Active Pharma Ingredient Market Size Forecast (2021-2026)
12.3.1 Europe: Active Pharma Ingredient Sales Forecast (2021-2026)
12.3.2 Europe: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.3.3 Europe: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Active Pharma Ingredient Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Active Pharma Ingredient Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Active Pharma Ingredient Market Size Forecast by Region (2021-2026)
12.5 Latin America Active Pharma Ingredient Market Size Forecast (2021-2026)
12.5.1 Latin America: Active Pharma Ingredient Sales Forecast (2021-2026)
12.5.2 Latin America: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.5.3 Latin America: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Active Pharma Ingredient Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Active Pharma Ingredient Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Active Pharma Ingredient Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharma Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Active Pharma Ingredient Market Segments
Table 2. Ranking of Global Top Active Pharma Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Active Pharma Ingredient Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Innovative Active Pharmaceutical Ingredients
Table 5. Major Manufacturers of Generic Active Pharmaceutical Ingredients
Table 6. Global Active Pharma Ingredient Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Active Pharma Ingredient Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Active Pharma Ingredient Sales by Regions 2015-2020 (MT)
Table 9. Global Active Pharma Ingredient Sales Market Share by Regions (2015-2020)
Table 10. Global Active Pharma Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Active Pharma Ingredient Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Active Pharma Ingredient Sales Share by Manufacturers (2015-2020)
Table 13. Global Active Pharma Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Active Pharma Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharma Ingredient as of 2019)
Table 15. Active Pharma Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Active Pharma Ingredient Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Active Pharma Ingredient Price (2015-2020) (USD/MT)
Table 18. Active Pharma Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Active Pharma Ingredient Product Type
Table 20. Date of International Manufacturers Enter into Active Pharma Ingredient Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 23. Global Active Pharma Ingredient Sales Share by Type (2015-2020)
Table 24. Global Active Pharma Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Active Pharma Ingredient Revenue Share by Type (2015-2020)
Table 26. Active Pharma Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 28. Global Active Pharma Ingredient Sales Share by Application (2015-2020)
Table 29. North America Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 30. North America Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 31. North America Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 33. North America Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 34. North America Active Pharma Ingredient Sales Market Share by Type (2015-2020)
Table 35. North America Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 36. North America Active Pharma Ingredient Sales Market Share by Application (2015-2020)
Table 37. Europe Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 38. Europe Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 39. Europe Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 41. Europe Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 42. Europe Active Pharma Ingredient Sales Market Share by Type (2015-2020)
Table 43. Europe Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 44. Europe Active Pharma Ingredient Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Active Pharma Ingredient Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Active Pharma Ingredient Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Active Pharma Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Active Pharma Ingredient Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Active Pharma Ingredient Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Active Pharma Ingredient Sales Market Share by Application (2015-2020)
Table 53. Latin America Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 54. Latin America Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 57. Latin America Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 58. Latin America Active Pharma Ingredient Sales Market Share by Type (2015-2020)
Table 59. Latin America Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 60. Latin America Active Pharma Ingredient Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Active Pharma Ingredient Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Active Pharma Ingredient Sales Market Share by Application (2015-2020)
Table 69. Teva Corporation Information
Table 70. Teva Description and Major Businesses
Table 71. Teva Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Teva Product
Table 73. Teva Recent Development
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Major Businesses
Table 76. Novartis Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Novartis Product
Table 78. Novartis Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Major Businesses
Table 86. Johnson & Johnson Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Recent Development
Table 89. Mylan Corporation Information
Table 90. Mylan Description and Major Businesses
Table 91. Mylan Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Mylan Product
Table 93. Mylan Recent Development
Table 94. North China Pharmaceutical Group Corporation Information
Table 95. North China Pharmaceutical Group Description and Major Businesses
Table 96. North China Pharmaceutical Group Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. North China Pharmaceutical Group Product
Table 98. North China Pharmaceutical Group Recent Development
Table 99. Dr. Reddy’s Laboratories Corporation Information
Table 100. Dr. Reddy’s Laboratories Description and Major Businesses
Table 101. Dr. Reddy’s Laboratories Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Dr. Reddy’s Laboratories Product
Table 103. Dr. Reddy’s Laboratories Recent Development
Table 104. Roche Corporation Information
Table 105. Roche Description and Major Businesses
Table 106. Roche Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Roche Product
Table 108. Roche Recent Development
Table 109. Aurobindo pharma Corporation Information
Table 110. Aurobindo pharma Description and Major Businesses
Table 111. Aurobindo pharma Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Aurobindo pharma Product
Table 113. Aurobindo pharma Recent Development
Table 114. Sun Pharmaceutical Industries Corporation Information
Table 115. Sun Pharmaceutical Industries Description and Major Businesses
Table 116. Sun Pharmaceutical Industries Active Pharma Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sun Pharmaceutical Industries Product
Table 118. Sun Pharmaceutical Industries Recent Development
Table 119. Boehringer Ingelheim GmbH Corporation Information
Table 120. Boehringer Ingelheim GmbH Description and Major Businesses
Table 121. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Boehringer Ingelheim GmbH Product
Table 123. Boehringer Ingelheim GmbH Recent Development
Table 124. Bayer Corporation Information
Table 125. Bayer Description and Major Businesses
Table 126. Bayer Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Bayer Product
Table 128. Bayer Recent Development
Table 129. BASF Corporation Information
Table 130. BASF Description and Major Businesses
Table 131. BASF Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. BASF Product
Table 133. BASF Recent Development
Table 134. DSM Corporation Information
Table 135. DSM Description and Major Businesses
Table 136. DSM Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. DSM Product
Table 138. DSM Recent Development
Table 139. Zhejiang Medicine Corporation Information
Table 140. Zhejiang Medicine Description and Major Businesses
Table 141. Zhejiang Medicine Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Zhejiang Medicine Product
Table 143. Zhejiang Medicine Recent Development
Table 144. Biocon Corporation Information
Table 145. Biocon Description and Major Businesses
Table 146. Biocon Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Biocon Product
Table 148. Biocon Recent Development
Table 149. Johnson Matthey Corporation Information
Table 150. Johnson Matthey Description and Major Businesses
Table 151. Johnson Matthey Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Johnson Matthey Product
Table 153. Johnson Matthey Recent Development
Table 154. Hisun Pharmacy Corporation Information
Table 155. Hisun Pharmacy Description and Major Businesses
Table 156. Hisun Pharmacy Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Hisun Pharmacy Product
Table 158. Hisun Pharmacy Recent Development
Table 159. Cambrex Corporation Information
Table 160. Cambrex Description and Major Businesses
Table 161. Cambrex Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Cambrex Product
Table 163. Cambrex Recent Development
Table 164. Shandong Xinhua Pharmaceutical Corporation Information
Table 165. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 166. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Shandong Xinhua Pharmaceutical Product
Table 168. Shandong Xinhua Pharmaceutical Recent Development
Table 169. Lonza group Corporation Information
Table 170. Lonza group Description and Major Businesses
Table 171. Lonza group Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Lonza group Product
Table 173. Lonza group Recent Development
Table 174. Huahai Pharmaceutical Corporation Information
Table 175. Huahai Pharmaceutical Description and Major Businesses
Table 176. Huahai Pharmaceutical Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 177. Huahai Pharmaceutical Product
Table 178. Huahai Pharmaceutical Recent Development
Table 179. Haerbin Pharmaceutical Group Corporation Information
Table 180. Haerbin Pharmaceutical Group Description and Major Businesses
Table 181. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 182. Haerbin Pharmaceutical Group Product
Table 183. Haerbin Pharmaceutical Group Recent Development
Table 184. Cipla Corporation Information
Table 185. Cipla Description and Major Businesses
Table 186. Cipla Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 187. Cipla Product
Table 188. Cipla Recent Development
Table 189. Tian Yao Corporation Information
Table 190. Tian Yao Description and Major Businesses
Table 191. Tian Yao Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 192. Tian Yao Product
Table 193. Tian Yao Recent Development
Table 194. Lupin Corporation Information
Table 195. Lupin Description and Major Businesses
Table 196. Lupin Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 197. Lupin Product
Table 198. Lupin Recent Development
Table 199. North East Pharmaceutical Corporation Information
Table 200. North East Pharmaceutical Description and Major Businesses
Table 201. North East Pharmaceutical Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 202. North East Pharmaceutical Product
Table 203. North East Pharmaceutical Recent Development
Table 204. Albemarle Corporation Information
Table 205. Albemarle Description and Major Businesses
Table 206. Albemarle Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 207. Albemarle Product
Table 208. Albemarle Recent Development
Table 209. Shandong Lukang Pharmaceutical Corporation Information
Table 210. Shandong Lukang Pharmaceutical Description and Major Businesses
Table 211. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 212. Shandong Lukang Pharmaceutical Product
Table 213. Shandong Lukang Pharmaceutical Recent Development
Table 214. Jiangsu Hengrui Medicine Corporation Information
Table 215. Jiangsu Hengrui Medicine Description and Major Businesses
Table 216. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 217. Jiangsu Hengrui Medicine Product
Table 218. Jiangsu Hengrui Medicine Recent Development
Table 219. Global Active Pharma Ingredient Sales Forecast by Regions (2021-2026) (MT)
Table 220. Global Active Pharma Ingredient Sales Market Share Forecast by Regions (2021-2026)
Table 221. Global Active Pharma Ingredient Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 222. Global Active Pharma Ingredient Revenue Market Share Forecast by Regions (2021-2026)
Table 223. North America: Active Pharma Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 224. North America: Active Pharma Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 225. Europe: Active Pharma Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 226. Europe: Active Pharma Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 227. Asia Pacific: Active Pharma Ingredient Sales Forecast by Region (2021-2026) (MT)
Table 228. Asia Pacific: Active Pharma Ingredient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 229. Latin America: Active Pharma Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 230. Latin America: Active Pharma Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 231. Middle East and Africa: Active Pharma Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 232. Middle East and Africa: Active Pharma Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 233. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 234. Key Challenges
Table 235. Market Risks
Table 236. Main Points Interviewed from Key Active Pharma Ingredient Players
Table 237. Active Pharma Ingredient Customers List
Table 238. Active Pharma Ingredient Distributors List
Table 239. Research Programs/Design for This Report
Table 240. Key Data Information from Secondary Sources
Table 241. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharma Ingredient Product Picture
Figure 2. Global Active Pharma Ingredient Sales Market Share by Type in 2020 & 2026
Figure 3. Innovative Active Pharmaceutical Ingredients Product Picture
Figure 4. Generic Active Pharmaceutical Ingredients Product Picture
Figure 5. Global Active Pharma Ingredient Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Cardiovascular Disease
Figure 8. Diabetes
Figure 9. Central Nervous System and Neurological Disorders
Figure 10. Endocrinology
Figure 11. Other Therapeutic Applications
Figure 12. Active Pharma Ingredient Report Years Considered
Figure 13. Global Active Pharma Ingredient Market Size 2015-2026 (US$ Million)
Figure 14. Global Active Pharma Ingredient Sales 2015-2026 (MT)
Figure 15. Global Active Pharma Ingredient Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Active Pharma Ingredient Sales Market Share by Region (2015-2020)
Figure 17. Global Active Pharma Ingredient Sales Market Share by Region in 2019
Figure 18. Global Active Pharma Ingredient Revenue Market Share by Region (2015-2020)
Figure 19. Global Active Pharma Ingredient Revenue Market Share by Region in 2019
Figure 20. Global Active Pharma Ingredient Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Active Pharma Ingredient Revenue in 2019
Figure 22. Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Active Pharma Ingredient Sales Market Share by Type (2015-2020)
Figure 24. Global Active Pharma Ingredient Sales Market Share by Type in 2019
Figure 25. Global Active Pharma Ingredient Revenue Market Share by Type (2015-2020)
Figure 26. Global Active Pharma Ingredient Revenue Market Share by Type in 2019
Figure 27. Global Active Pharma Ingredient Market Share by Price Range (2015-2020)
Figure 28. Global Active Pharma Ingredient Sales Market Share by Application (2015-2020)
Figure 29. Global Active Pharma Ingredient Sales Market Share by Application in 2019
Figure 30. Global Active Pharma Ingredient Revenue Market Share by Application (2015-2020)
Figure 31. Global Active Pharma Ingredient Revenue Market Share by Application in 2019
Figure 32. North America Active Pharma Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Active Pharma Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Active Pharma Ingredient Sales Market Share by Country in 2019
Figure 35. North America Active Pharma Ingredient Revenue Market Share by Country in 2019
Figure 36. U.S. Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Active Pharma Ingredient Market Share by Type in 2019
Figure 41. North America Active Pharma Ingredient Market Share by Application in 2019
Figure 42. Europe Active Pharma Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Active Pharma Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Active Pharma Ingredient Sales Market Share by Country in 2019
Figure 45. Europe Active Pharma Ingredient Revenue Market Share by Country in 2019
Figure 46. Germany Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 49. France Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Active Pharma Ingredient Market Share by Type in 2019
Figure 57. Europe Active Pharma Ingredient Market Share by Application in 2019
Figure 58. Asia Pacific Active Pharma Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Active Pharma Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Active Pharma Ingredient Sales Market Share by Region in 2019
Figure 61. Asia Pacific Active Pharma Ingredient Revenue Market Share by Region in 2019
Figure 62. China Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 63. China Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 69. India Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Active Pharma Ingredient Market Share by Type in 2019
Figure 85. Asia Pacific Active Pharma Ingredient Market Share by Application in 2019
Figure 86. Latin America Active Pharma Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Active Pharma Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Active Pharma Ingredient Sales Market Share by Country in 2019
Figure 89. Latin America Active Pharma Ingredient Revenue Market Share by Country in 2019
Figure 90. Mexico Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Active Pharma Ingredient Market Share by Type in 2019
Figure 97. Latin America Active Pharma Ingredient Market Share by Application in 2019
Figure 98. Middle East and Africa Active Pharma Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Active Pharma Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Active Pharma Ingredient Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Active Pharma Ingredient Revenue Market Share by Country in 2019
Figure 102. Turkey Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Active Pharma Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Active Pharma Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Active Pharma Ingredient Market Share by Type in 2019
Figure 109. Middle East and Africa Active Pharma Ingredient Market Share by Application in 2019
Figure 110. North America Active Pharma Ingredient Sales Growth Rate Forecast (2021-2026) (MT)
Figure 111. North America Active Pharma Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Active Pharma Ingredient Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. Europe Active Pharma Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Active Pharma Ingredient Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Asia Pacific Active Pharma Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Active Pharma Ingredient Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Latin America Active Pharma Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Active Pharma Ingredient Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Middle East and Africa Active Pharma Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
インスリン有効成分の世界市場（～2026年） Market Analysis and Insights: Global Insulin Active Pharmaceutical Ingredient Market The global Insulin Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Active Pharmaceutical Ing…- ジェネリック医薬品有効成分の世界市場（～2026年） Market Analysis and Insights: Global Generic Active Pharmaceutical Ingredients Market The global Generic Active Pharmaceutical Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Generic Active Pharmaceutical I…
- 高薬理活性原薬 (HPAPI)の世界市場（～2026年） The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) = 10µg/m3. Market Analysis and Insights: Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market The global High Potency Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX m…
- HPAPI（高力価有効成分）の世界市場（～2026年） Market Analysis and Insights: Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market The global HPAPI (High Potency Active Pharmaceutical Ingredients) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global HPAPI…
- 高性能医薬品有効成分（HPAPI）の世界市場（～2026年） Market Analysis and Insights: Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market The global High Performance Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Glob…